check_circleStudy Completed

Diagnostic Imaging

Bayer Identifier:

Trial_86058

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Iopromide (SHL414A) versus amidotrizoate (Visotrast-370) in angiocardiography in 50 newborns and infants

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

13 - 3 Years
  • -

  • -

Trial summary

Enrollment Goal
50
Trial Dates
July 1986 - April 1987
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Ultravist (Iopromide, BAY86-4877)
Accepts Healthy Volunteer
N/A

Trial design

Double-blind comparative clinical study of iopromide (SHL414A) versus amidotrizoate (Visotrast-370) in angiocardiography in 50 newborns and infants
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.